The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Microbiome at the Frontier of Personalized Medicine
Open accessAbstract
&NA; The genomic revolution promises to transform our approach to treat patients by individualizing treatments, reducing adverse events, and decreasing health care costs. The early advances using this have been realized primarily by optimizing preventive and therapeutic approaches in cancer using human genome sequencing. The ability to characterize the microbiome, which includes all the microbes that reside within and upon us and all their genetic elements, using next‐generation sequencing allows us to now incorporate this important contributor to human disease into developing new preventive and therapeutic strategies. In this review we highlight the importance of the microbiome in all aspects of human disease, including pathogenesis, phenotype, prognosis, and response to treatment, as well as their role as diagnostic and therapeutic biomarkers. We provide a role for next‐generation sequencing in both precise microbial identification of infectious diseases and characterization of microbial communities and their function. Taken together, the microbiome is emerging as an integral part of precision medicine approach as it not only contributes to interindividual variability in all aspects of a disease but also represents a potentially modifiable factor that is amenable to targeting by therapeutics. Abbreviations and Acronyms: CD = Crohn disease; FMT = fecal microbiota transplant; IBD = inflammatory bowel disease; PFGE = pulse‐field gel electrophoresis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Interestingly, short-term dietary effects on the microbiome seem to be easily reversible even when using extreme dietary interventions.(77) Moreover, short-term dietary interventions have shown to have beneficial effects on the host and gut microbiome.”
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“Bifidobacterium has been found to augment tumor control in mouse models of melanoma treated with antieprogrammed deathligand 1.(54) Similarly in humans, Bacteroides have been suggested to be responsible for antitumor effects of cytotoxicT-lymphocyte associatedprotein 4 blockade, commonly used for cancer immunotherapy.”
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Self-citationSeparation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis
Schwartz, D. C., & Cantor, C. R. (1984) · Cell · doi:10.1016/0092-8674(84)90301-5 · Cited by 2,841
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302 · cited 1×
“Alteration in microbial communities (often referred to as dysbiosis) has been shown to be associated with diseases ranging from infectious (Clostridium difficile infection) to inflammatory (inflammatory bowel disease [IBD] and rheumatoid arthritis) and metabolic (diabetes and obesity) diseases, suggesting an important…”
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E. G., Abramson, S. B., et al. (2013) · eLife · doi:10.7554/elife.01202 · Cited by 2,047
Blundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., & Spratt, B. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1518-1530.2004 · Cited by 1,861
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y. S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.001 · Cited by 1,731
Diet-induced extinctions in the gut microbiota compound over generations
Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K., Wingreen, N. S., & Sonnenburg, J. L. (2016) · Nature · doi:10.1038/nature16504 · Cited by 1,730
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Joensen, K. G., Scheutz, F., Lund, O., Hasman, H., Kaas, R. S., Nielsen, E. M., & Aarestrup, F. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03617-13 · Cited by 1,409
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
PATRIC, the bacterial bioinformatics database and analysis resource
Wattam, A. R., Abraham, D., Dalay, O., Disz, T. L., Driscoll, T., Gabbard, J. L., Gillespie, J. J., Gough, R., Hix, D., Kenyon, R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1099 · Cited by 1,243
The vocabulary of microbiome research: a proposal
Marchesi, J. R., & Ravel, J. (2015) · Microbiome · doi:10.1186/s40168-015-0094-5 · Cited by 1,220
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
Evolution of MRSA During Hospital Transmission and Intercontinental Spread
Harris, S. R., Feil, E. J., Holden, M. T. G., Quail, M. A., Nickerson, E. K., Chantratita, N., Gardete, S., Tavares, A., Day, N., Lindsay, J. A., et al. (2010) · Science · doi:10.1126/science.1182395 · Cited by 1,091
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Swaminathan, B., Barrett, T. J., Hunter, S. B., Tauxe, R. V., & the CDC PulseNet Task Force (2001) · Emerging Infectious Diseases · doi:10.3201/eid0703.010303 · Cited by 1,073
Willing, B. P., Dicksved, J., Halfvarson, J., Andersson, A. F., Lucio, M., Zheng, Z., Järnerot, G., Tysk, C., Jansson, J. K., & Engstrand, L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.049 · Cited by 1,032
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
Wilson, M. R., Naccache, S. N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., Salamat, S. M., Somasekar, S., Federman, S., Miller, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401268 · Cited by 977
Multiplex PCR for the detection of tetracycline resistant genes
Ng, L.-K., Martin, I., Alfa, M., & Mulvey, M. (2001) · Molecular and Cellular Probes · doi:10.1006/mcpr.2001.0363 · Cited by 870
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
Chen, J., Wright, K., Davis, J. M., Jeraldo, P., Marietta, E. V., Murray, J., Nelson, H., Matteson, E. L., & Taneja, V. (2016) · Genome Medicine · doi:10.1186/s13073-016-0299-7 · Cited by 858
Self-citationTransforming clinical microbiology with bacterial genome sequencing
Didelot, X., Bowden, R., Wilson, D. J., Peto, T. E. A., & Crook, D. W. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3226 · Cited by 799
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
Host genetic variation impacts microbiome composition across human body sites
Blekhman, R., Goodrich, J. K., Huang, K., Sun, Q., Bukowski, R., Bell, J. T., Spector, T. D., Keinan, A., Ley, R. E., Gevers, D., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0759-1 · Cited by 745
Donia, M. S., Cimermancic, P., Schulze, C. J., Wieland Brown, L. C., Martin, J., Mitreva, M., Clardy, J., Linington, R. G., & Fischbach, M. A. (2014) · Cell · doi:10.1016/j.cell.2014.08.032 · Cited by 705
A robust SNP barcode for typing Mycobacterium tuberculosis complex strains
Coll, F., McNerney, R., Guerra-Assunção, J. A., Glynn, J. R., Perdigão, J., Viveiros, M., Portugal, I., Pain, A., Martin, N., & Clark, T. G. (2014) · Nature Communications · doi:10.1038/ncomms5812 · Cited by 697
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Li, J., Sung, C. Y. J., Lee, N., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 626
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly, C. R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., Moore, T., & Wu, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.008 · Cited by 572
Self-citationKristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561 · cited 1×
“The clinical efficacy of currently available probiotics is difficult to assess given the small sample sizes limiting the power, heterogeneity in strains of bacteria used, end points, duration of treatment and molecular methods of studying the gutmicrobiota, recording of baseline measurements such as diet, and often a…”
Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
Köser, C. U., Ellington, M. J., Cartwright, E. J. P., Gillespie, S. H., Brown, N. M., Farrington, M., Holden, M. T. G., Dougan, G., Bentley, S. D., Parkhill, J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002824 · Cited by 544
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Nascimento, M., Sousa, A., Ramirez, M., Francisco, A. P., Carriço, J. A., & Vaz, C. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw582 · Cited by 453
Synthetic Biology Moving into the Clinic
Ruder, W. C., Lu, T., & Collins, J. J. (2011) · Science · doi:10.1126/science.1206843 · Cited by 412
Synthetic Biology and Personalized Medicine
Jain, K. K. (2013) · Medical Principles and Practice · doi:10.1159/000341794 · Cited by 376
Keim, P., Van Ert, M. N., Pearson, T., Vogler, A. J., Huynh, L. Y., & Wagner, D. M. (2004) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2004.02.005 · Cited by 339
Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses
Korem, T., Zeevi, D., Zmora, N., Weissbrod, O., Bar, N., Lotan-Pompan, M., Avnit-Sagi, T., Kosower, N., Malka, G., Rein, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.002 · Cited by 318
Self-citationViladomiu, M., Kivolowitz, C., Abdulhamid, A., Dogan, B., Victorio, D., Castellanos, J. G., Woo, V., Teng, F., Tran, N. L., Sczesnak, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9655 · Cited by 313
Application of Whole-Genome Sequencing for Bacterial Strain Typing in Molecular Epidemiology
Salipante, S. J., SenGupta, D. J., Cummings, L. A., Land, T. A., Hoogestraat, D. R., & Cookson, B. T. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-14 · Cited by 290
Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?
Bachmann, B. O., Van Lanen, S. G., & Baltz, R. H. (2014) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-013-1389-9 · Cited by 276
Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome
Whitaker, W. R., Shepherd, E. S., & Sonnenburg, J. L. (2017) · Cell · doi:10.1016/j.cell.2017.03.041 · Cited by 244
Bennet, S. M. P., Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Öhman, L., & Simrén, M. (2018) · Gut · doi:10.1136/gutjnl-2016-313128 · Cited by 225
Wacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Mäki, M., & Mättö, J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029a9 · Cited by 207
New developments in microbial interspecies signaling
Shank, E. A., & Kolter, R. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.01.003 · Cited by 204
Khanna, S., Montassier, E., Schmidt, B. A., Patel, R., Knights, D., Pardi, D. S., & Kashyap, P. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13750 · Cited by 137
Self-citationSeekatz, A. M., Rao, K. K., Santhosh, K., & Young, V. B. (2016) · Genome Medicine · doi:10.1186/s13073-016-0298-8 · Cited by 129
An Economic Evaluation of PulseNet
Scharff, R. L., Besser, J. M., Sharp, D. J., Jones, T. F., Peter, G.-S., & Hedberg, C. W. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.09.018 · Cited by 115
MetaMLST: multi-locus strain-level bacterial typing from metagenomic samples
Zolfo, M., Tett, A., Jousson, O., Donati, C., & Segata, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw837 · Cited by 103
Whole genome sequencing in the prevention and control of Staphylococcus aureus infection
Price, J. R., Didelot, X., Crook, D. W., Llewelyn, M., & Paul, J. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.10.003 · Cited by 85
Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice
Smits, S. A., Marcobal, A. M., Higginbottom, S. K., Sonnenburg, J. L., & Kashyap, P. (2016) · mSystems · doi:10.1128/msystems.00098-16 · Cited by 84
Self-citationBioengineered probiotics, a strategic approach to control enteric infections
Amalaradjou, M. A. R., & Bhunia, A. K. (2013) · Bioengineered · doi:10.4161/bioe.23574 · Cited by 74
Jolley, K. A., & Maiden, M. C. J. (2013) · Eurosurveillance · doi:10.2807/ese.18.04.20379-en · Cited by 63
Cunningham, S. A., Chia, N., Jeraldo, P., Quest, D. J., Johnson, J. A., Boxrud, D. J., Taylor, A., Chen, J., Jenkins, G. D., Drucker, T., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-17 · Cited by 63
Self-citationThe human microbiome is a source of therapeutic drug targets
Wallace, B. D., & Redinbo, M. R. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.011 · Cited by 62
Antibiotics and the art of bacterial war
Cornforth, D. M., & Foster, K. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513608112 · Cited by 60
Veenemans, J., Overdevest, I. T. M. A., Snelders, E., Willemsen, I., Hendriks, Y., Adesokan, A. M., Doran, G., Bruso, S., Rolfe, A., Pettersson, A. M., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-14 · Cited by 57
Antibiotics as Anti-Inflammatory and Immunomodulatory Agents
Rubin, B. K., & Tamaoki, J. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/b137084 · Cited by 50
Sahl, J. W., Schupp, J. M., Rasko, D. A., Colman, R. E., Foster, J. T., & Keim, P. (2015) · Genome Medicine · doi:10.1186/s13073-015-0176-9 · Cited by 45
Galatti, L., Giustini, S. E., Sessa, A., Polimeni, G., Salvo, F., Spina, E., & Caputi, A. P. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.08.003 · Cited by 41
Viau, R. A., Kiedrowski, L. M., Kreiswirth, B. N., Adams, M. D., Pérez, F., Marchaim, D., Guerrero, D. M., Kaye, K. S., Logan, L. K., Villegas, M. V., et al. (2017) · Pathogens and Immunity · doi:10.20411/pai.v1i2.99 · Cited by 11
Scholz, C. F. P., & Jensen, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6673-8_7 · Cited by 9
Cited by
Human gut microbiome: Hopes, threats and promises
Cani, P. D. (2018) · Gut · doi:10.1136/gutjnl-2018-316723 · Cited by 1,386
Shaping the Future of Probiotics and Prebiotics
Cunningham, M., Azcarate-Peril, M. A., Barnard, A., Benoit, V., Grimaldi, R., Guyonnet, D., Holscher, H. D., Hunter, K., Manurung, S., Obis, D., et al. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.01.003 · Cited by 637
Marcos-Zambrano, L. J., Karaduzovic-Hadziabdic, K., Loncar Turukalo, T., Przymus, P., Trajkovik, V., Aasmets, O., Berland, M., Gruca, A., Hasic, J., Hron, K., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.634511 · Cited by 416
Yu, L. C.-H. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0483-8 · Cited by 399
A predictive index for health status using species-level gut microbiome profiling
Gupta, V. K., Kim, M., Bakshi, U., Cunningham, K. Y., Davis, J. M., Lazaridis, K. N., Nelson, H., Chia, N., & Sung, J. (2020) · Nature Communications · doi:10.1038/s41467-020-18476-8 · Cited by 338
Self-citation
Metadata
- Authors
- Kashyap, P. C., Chia, N., Nelson, H., Segal, E., & Elinav, E.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 92
- Issue
- 12
- Pages
- 1855-1864
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2771485505
- Cited by
- 274
- References
- 73
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.